Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
2,7-Pyrrolo[2,1- f][1,2,4]triazines as JAK2 inhibitors: Modification of target structure to minimize reactive metabolite formationWeinberg, Linda R. ; Albom, Mark S. ; Angeles, Thelma S. ; Breslin, Henry J. ; Gingrich, Diane E. ; Huang, Zeqi ; Lisko, Joseph G. ; Mason, Jennifer L. ; Milkiewicz, Karen L. ; Thieu, Tho V. ; Underiner, Ted L. ; Wells, Gregory J. ; Wells-Knecht, Kevin J. ; Dorsey, Bruce D.Bioorganic & medicinal chemistry letters, 2011-12, Vol.21 (24), p.7325-7330 [Periódico revisado por pares]Amsterdam: Elsevier LtdTexto completo disponível |
|
2 |
Material Type: Artigo
|
Adjuvant Immunotherapy of Feline Fibrosarcoma with Recombinant Feline Interferon-ωHampel, V ; Schwarz, B ; Kempf, C ; Kostlin, R ; Schillinger, U ; Kuchenhoff, H ; Fenske, N ; Brill, T ; Hirschberger, JJournal of veterinary internal medicine, 2007-11, Vol.21 (6), p.1340-1346 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Administration of Subcutaneous Monoclonal Antibodies in Patients With CancerRodrigues Ferreira, Anne ; Farias Azevedo, ElieteOncology Nursing Forum, 2019-01, Vol.46 (1), p.E38-E47 [Periódico revisado por pares]United States: Oncology Nursing SocietyTexto completo disponível |
|
4 |
Material Type: Livro
|
Advances in DNA Repair in Cancer TherapyPanasci, Lawrence ; Alaoui-Jamali, Moulay ; Aloyz, Raquel Alaoui-Jamali, Moulay ; Aloyz, Raquel ; Panasci, Lawrence ; Alaoui-Jamali, Moulay ; Panasci, Lawrence ; Aloyz, RaquelNew York, NY: Springer Nature 2012Sem texto completo |
|
5 |
Material Type: Artigo
|
Adverse events induced by nivolumab and ipilimumab combination regimensSomekawa, Kohei ; Horita, Nobuyuki ; Kaneko, Ayami ; Tagami, Yoichi ; Fukuda, Nobuhiko ; Matsumoto, Hiromi ; Namkoong, Ho ; Fujiwara, Yu ; Minegishi, Kaoru ; Fukumoto, Takeshi ; Watanabe, Keisuke ; Hara, Yu ; Kobayashi, Nobuaki ; Kaneko, TakeshiTherapeutic advances in medical oncology, 2022, Vol.14, p.17588359211058393-17588359211058393 [Periódico revisado por pares]London, England: SAGE PublicationsTexto completo disponível |
|
6 |
Material Type: Artigo
|
Antiangiogenic scheduling of lower dose cancer chemotherapyGately, S ; Kerbel, RThe cancer journal (Sudbury, Mass.), 2001-09, Vol.7 (5), p.427 [Periódico revisado por pares]United StatesTexto completo disponível |
|
7 |
Material Type: Livro
|
Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target CancerOlivier, Kenneth J., Jr ; Hurvitz, Sara ANewark: Wiley 2016Texto completo disponível |
|
8 |
Material Type: Livro
|
Anticancer Drug DevelopmentBaguley, Bruce C ; Kerr, David JSan Diego: Elsevier Science 2001Texto completo disponível |
|
9 |
Material Type: Livro
|
Anticancer Drug Development Guide: Preclinical Screening, Clinical Trials, and ApprovalTeicher, Beverly ATotowa, NJ: Humana Press 1997Texto completo disponível |
|
10 |
Material Type: Artigo
|
Antiemetic medication for prevention and treatment of chemotherapy‐induced nausea and vomiting in childhoodPhillips, Robert S ; Friend, Amanda J ; Gibson, Faith ; Houghton, Elizabeth ; Gopaul, Shireen ; Craig, Jean V ; Pizer, Barry ; Phillips, Robert SCochrane database of systematic reviews, 2016-02, Vol.2016 (2), p.CD007786 [Periódico revisado por pares]Chichester, UK: John Wiley & Sons, LtdTexto completo disponível |